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ABSTRACT
Introduction:  functional  limitation is  a result  of  sarcopenia and is
associated with  loss  of  skeletal  muscle  mass  (SMM).  Cost-effective
methods are important for the identification of sarcopenia. 
Objective: to propose cutoff points for normalized calf circumference
(CC)  in  order  to  identify  low SMM in  older  women based  on  their
functional limitation. 
Methods: in this descriptive, cross-sectional study the CC values of a
young female sample (n = 78) were used to establish cutoff points (-2
SD) for low SMM in older women (n = 67). Functional limitation was
identified by the six-minute walk test (≤ 400 m). CC was normalized
by body mass, height, and BMI. The diagnostic accuracy of CC was
calculated with a ROC curve, using functional limitation as standard. 
Results:  cutoff points and area under the curve (AUC) were: CC (≤
28.5; 0.62); CC·body mass-1 (≤ 0.40; 0.63); CC·height-2 (≤ 8.52; 0.55)
and  CC·BMI-1 (≤  1.10;  0.73).  Only  CC·BMI-1 achieved  a  desirable
accuracy (AUC > 0.7) to distinguish functional limitation.
Conclusion:  the accuracy attained supports the use of  CC·BMI-1  to
identify low SMM in older women. In the clinical context it is possible
to  predict  the  risk  of  sarcopenia  when  sophisticated  methods  for
determining SMM are not available.
Keywords:  Aged.  Anthropometry.  Frail  elderly. Mobility  disability.
Muscle mass.
RESUMEN
Introducción:  la  limitación  funcional  es  consecuencia  de  la
sarcopenia y se asocia con la pérdida de masa muscular esquelética
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(MME). Los métodos rentables son importantes para la identificación
de la sarcopenia. 
Objetivo:  proponer  puntos  de  corte  para  la  circunferencia  de  la
pantorrilla (CP), normalizada para identificar un MME bajo en mujeres
mayores en función de su limitación funcional. 
Métodos:  en  este  estudio  descriptivo  de  carácter  transversal  se
utilizaron los valores de CP de una muestra de mujeres jóvenes (n =
78) para establecer los puntos de corte (-2 DS) de la MME baja en las
mujeres  mayores  (n  =  67).  La  limitación  funcional  se  identificó
mediante la prueba de la marcha de seis minutos (≤ 400 m). La CP se
normalizó  por  la  masa  corporal,  la  altura  y  el  IMC.  La  precisión
diagnóstica de la CP se calculó con la curva ROC, utilizando como
estándar la limitación funcional. 
Resultados: los puntos de corte y el área bajo la curva (AUC) fueron:
CP (≤ 28,5; 0,62); CP·masa corporal-1 (≤ 0,40; 0,63); CP·altura-2 (≤
8,52; 0,55) y CP·IMC-1 (≤ 1,10; 0,73). Solo el CP·IMC-1 logró la precisión
deseable (AUC > 0,7) para distinguir la limitación funcional.
Conclusión: la precisión alcanzada respalda el uso de CP·IMC-1 para
identificar la MME baja en las mujeres mayores. En el contexto clínico
es posible predecir el riesgo de sarcopenia cuando no se dispone de
métodos sofisticados para determinar la MME.
Palabras  clave:  Envejecido.  Antropometría.  Ancianos  frágiles.
Discapacidad de movilidad. Masa muscular.
INTRODUCTION
Functional  limitation  caused  by  reduced  mobility  is  an  age-related
phenomenon  that  negatively  affects  the  physical  independence  of
older adults  (1). One of the main consequences of this limitation is
sarcopenia,  a  disease  characterized  by  low  muscle  strength  and
reduced  amount  of  skeletal  muscle  mass  (SMM)  (2).  Sarcopenia
affects 10 percent of  older adults worldwide  (3) and 60 percent of
older women in Brazil (4). When untreated, sarcopenia exposes older
adults to functional impairment, mobility disorders, increased risk of
falls,  loss  of  functional  independence,  physical  frailty,  increases  in
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hospitalization,  decreased  quality  of  life,  and  increased  risk  of
premature death (5). Therefore, the early identification of the disease
considerably reduces the economic impact on health systems and on
the personal and social burdens of care for older adults (6). 
For  the  diagnostic  confirmation  of  sarcopenia  two  conditions  are
required:  reduced  muscle  strength  and  decreased  SMM  (2).  SMM
parameters can be obtained from dual-energy X-ray absorptiometry
(DXA), bioelectrical impedance analysis, magnetic resonance imaging,
computed  tomography,  muscle  biopsy,  or  magnetic  resonance
spectroscopy (2). However, these require skilled health professionals,
and  are  high-cost  and difficult  to  access  in  the  context  of  regular
clinical practice, particularly in low- and middle-income countries (7).
Although the measurement of SMM by DXA is one of the most widely
used procedures (4), this test lacks a good relationship with reduced
mobility  as  associated  with  sarcopenia  (8),  and  thus  has  limited
diagnostic value (8). On the other hand, calf circumference (CC) is a
cost-effective  and  expedient  alternative  for  estimating  SMM, a
clinically relevant outcome in community-dwelling older adults (2,9).
Although CC has a good association with mobility in older adults (10),
this relationship is characterized by an inverted U-shaped form (9).
Normalizing CC by body size, as recommended, will correct this non-
linear relationship (2). Normalization of SMM is already performed on
selected DXA variables, such as appendicular skeletal muscle mass
(ASMM),  usually  corrected  relative  to  body  size  (ASMM·height-2,
ASMM·body mass-1 or ASMM·BMI-1) (11). Unfortunately, these variables
have  weak  associations  with  clinically  relevant  outcomes  in  older
adults  (8,12).  Moreover,  the  identification  of  a  low  SMM  index
(ASMM·height-2) includes the absolute value of CC (Table III)  (13-22)
for generating cutoff points, which will  penalize older adults with a
smaller body size. 
Given the limitations evident in quantifying SMM, the objective of this
study was to propose cutoff points for CC normalized by body size to
identify low SMM in older women with regard to functional limitation.
Our  hypothesis  is  that  normalization  of  CC  provides  a  pragmatic
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indicator  of  functional  limitation  that,  in  turn,  indicates  risk  of
sarcopenia. Therefore, monitoring functional limitation could alert to
the degenerative consequences resulting from the ageing process in
women at a public healthcare level.
MATERIALS AND METHODS
Participants and settings (age, gender, country socioeconomic
status, and so on)
´
For this descriptive and cross-sectional study a sample was comprised
of  two  age  groups  from  the  same  population  who  attended  our
laboratory  between  October  2016  and  June  2017:  the  first  group
consisted of 79 young women aged between 18 and 30 years (23.9 ±
3.4 years), and the second group of 69 older women aged between 60
and  85  years  (69.8  ±  6.0  years).  A  sample  size  calculation  was
previously performed (n = [Zy SD / ε]2) from the maximum desired
error (ε ≤ 1 %), trust level (Zy = 0.95) and population variability (SD).
The  main  variable  (CC)  for  the  age  group  of  women with  greater
variability  obtained  from a  compatible  population  was  adopted  as
reference  (SD  =  4.29  cm)  (21).  The  minimum  sample  size  was
calculated (n = 142).
The voluntary recruitment of participants took place through personal
invitations,  and  electronic  and  printed  dissemination  in  the
community.  Young  women  met  the  following  criteria:  not  taking
antidepressants or stimulants that affect the central nervous system,
self-declared to be in good health, not having amputated body parts,
not performing more than 10 hours/week of physical training. Older
women should be able to walk independently, not have uncontrolled
chronic illnesses, acute infections, tumors, back pain, hip, and knee
prosthesis, unintentional weight loss of more than three kg in the last
three  months.  Criteria  for  discontinuing  the  study  were  reports  of
serious  balance  problems,  and  sequelae  of  stroke  and  cognitive
impairment.  All participants gave their full and informed consent to
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take part, and the study was designed and conducted in accordance
with  the  Declaration  of  Helsinki  and  approved  by  the  Institution’s
Ethics  Committees  (CAAE:  57511516.5.0000.5659  and
54345016.6.0000.5659).
Instruments and procedures
All measurements were taken individually at the University Hospital of
Ribeirao Preto School of Medicine, University of Sao Paulo, Brazil (HC-
FMRP-USP), in the morning from 9 am to 11 am). Data collection took
place  in  a  single  session,  by  the  same examiners  trained  in  each
measure.  The  older  women  cognitive  deficit  was  verified  by  a
questionnaire. Anthropometric measurements of height to the nearest
0.01 m and body weight (kg) were performed (26) for all women, and
BMI was calculated (kg·m-2). Other measures performed are descried
below.
Cognitive assessment
To ensure the aptitude and cognitive capacity of older women, the
Mini  Mental  State  Examination  (MMSE)  was  used  in  the  reduced
version of  19 points  (27).  Participants who scored 12 or  less were
considered to have a cognitive deficit  and were excluded from the
analysis.
Anthropometric assessments
From the measurements of body mass in kg and height in cm body
mass  index  (BMI;  kg·m-2)  was  determined.  CC  was  measured
according  to  a  standardized  procedure  (26) with  recording  of  the
median from 3 measurements.  For analyses CC was considered as
absolute (cm) and normalized: CC·body mass-1 in cm·kg-1, CC·height-2
in cm·m-2 and CC·BMI-1 in cm·kg-1·m-2.
Six-minute walk test 
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To assess physical function the six-minute walk test was performed on
a flat, non-slip surface, 30 meters in length, with calibrated markings
every  three  meters.  Older  women  were  asked  to  walk  as  fast  as
possible  for  six  minutes  and  were  allowed  to  rest  during  the  test
without stopping the clock. Total distance covered was recorded to the
nearest 3 meters. Functional limitation was identified when walking
distance was ≤ 400 m (1).
Statistical analysis
Descriptive  statistics  included  central  tendency  and  confidence
interval  (95 %  CI).  Cutoff  points  were  established  for  absolute  or
normalized CC considering -2 SD compared to the mean CC of young
and  healthy  women,  as  recommended  by  the  EWGSOP  for  SMM
parameters (2). The likelihood of different CC expressions to explain
the  occurrence  of  functional  limitation  was  confirmed  by  logistic
regression. Additionally, significance in statistical models was verified
using  the  chi-square (χ2) test  and  their  coefficients  of  logistic
regression.  Finally,  the  ability  of  CC  to  discriminate  functional
limitation was illustrated using an area under the ROC curve (AUC)
value  >  0.70 (28). For  this  analysis  we  adopted  a  dichotomous
classification  for  the  presence  (1)  or  absence  (0)  of  a  functional
limitation. All analyses were performed on the SPSS 25.0 and MedCalc
15.2 programs, with a previously established level of significance (α =
5 %).
RESULTS
Figure 1 shows the flowchart for  recruiting study participants.  One
hundred and forty-eight women were initially eligible for the studies.
After applying exclusion criteria, the analyses were carried out in 145
women (78 young).
Descriptive  statistics  for  MMSE  score,  chronological  age,
anthropometric variables, and walking distance are shown in table I.
Older  women  were  older,  and  had  greater  body  mass,  BMI,  and
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absolute CC. Younger women were taller (10 cm) and weighed less (6
kg) than their older counterparts. The higher BMI found in older (≅ 27
kg·m-2)  compared  to  younger  women  (≅  21  kg·m-2)  illustrates  a
greater  weight  gain with age. Likewise,  the highest  normalized CC
values observed in young women showed an inverse relationship with
absolute CC according to age. From a functional perspective nearly
two thirds of the older women (39 %; n = 26) did not achieve a good
functional score on the walk test.
Normalized CC cutoff points showed an inverse relationship with age
when compared to absolute CC (Table I).  CC values normalized by
body mass (0.40 cm·kg-1), height squared (8.52 cm·m-2) or BMI (1.10
cm·kg-1·m-2) also had a different relationship for each age group. All
mean CC values were within the 95 % confidence threshold, which
suggests high reliability even when replicated for other samples of the
same population. 
The accuracy of detecting a functional limitation using different CC
expressions  is  shown  in  table  II.  The  p-values  of  the  regressions
originating from CC as normalized by body mass (p = 0.027) and BMI
(p = 0.001) demonstrate the likelihood of significantly accounting for
the occurrence of functional limitation. In fact, only CC·BMI-1 presented
an acceptable accuracy (AUC > 0.70), as shown in figure 2. There is
statistical significance in the chi-quadratic distribution (Wald = 8.72; p
= 0.001). From the beta exponent (b = 0.002) of the CC·BMI-1 variable
(Table  II)  it  was  possible  to  calculate  the  likelihood  of  decreasing
functional  limitation  (i.e.,  0.002  -  1  =  -0.998).  That  is,  for  every
increased  tenth  of  unit  (0.1  cm·kg-1·m-2)  of  CC·BMI-1 there  is  a
reduction in the chances of  functional  limitation by  ≅  10 %. As an
example from our findings (Table II), mean CC·BMI-1 in young women
(1.6  cm·kg-1·m-2)  compared to older  women (1.3  cm·kg-1·m-2)  has a
difference  of  0.3  cm·kg-1·m-2.  This  represents  a  reduction  in  the
chances of functional limitation for young women by around 30 %.
Although the adjustment of CC by body mass (Table II) was significant
(χ2  = 4.89; p = 0.027), the extremely low odds ratio value (< 0.001)
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did not sufficiently explain the occurrence of functional limitation. This
finding  was  confirmed  when  the  analysis  of  the  ROC  curve  for
CC·body  mass-1 showed  insufficient  sensitivity  (27 %),  specificity
(98 %), and AUC (0.63) values. On the other hand, the CC·BMI-1 cutoff
point presented an acceptable AUC (0.73), even though its sensitivity
(85 %) was greater than its specificity (54 %).
After applying the cutoff point of the CC·BMI-1  (≤ 1.10 cm·kg-1·m-2) in
our sample, about 12 % of older women were classified with low SMM
(n = 7/60). Figure 3 further illustrates the relationship between CC
and mobility in older women, as expressed by the distance covered in
the  six-minute  walk  test.  The  inverted  U-shaped  relationship
expressed  by  absolute  CC  (a)  versus  the  resulting  linearity  when
normalized by BMI (b) may be seen.
Our  model  (CC·BMI-1),  in  addition  to  correcting  the  non-linear
relationship  between  CC  and  mobility,  showed  a  positive  and
significant correlation between adjusted CC and mobility (r = 0.48; p
< 0.001). 
DISCUSSION
Our aim was to develop cutoff points for CC normalized by body size
to  identify  low  SMM  in  older  women  with  respect  to  functional
limitation. The cutoff points of CC when normalized by body size were
more  effective  than  absolute  CC  in  identifying  low  SMM  in  older
women.  CC·body  mass-1  and  CC·BMI-1 explained  (p  <  0.05)  the
likelihood of occurrence of functional limitation (walking ≤ 400 m in
six  minutes).  But  only  CC  normalized  by  BMI  (1.10  cm·kg-1·m-2)
achieved an acceptable sensitivity (85 %) and accuracy (AUC > 0.70)
(28) to  identify  the  low SMM associated  with  functional  limitation.
Furthermore, this model (CC·BMI-1) was able to linearize the inverted
U-shaped relationship usually observed in absolute CC expressions.
Absolute CC is accurate to estimate and identify a low level of SMM in
older  women  (15);  however,  when  normalized  by  body  size,
particularly BMI (2), it avoids false negatives for functional limitation
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and sarcopenia.  An absolute CC value below 27 cm alerts  to care
needs for older women to perform their daily activities (29). However,
when absolute CC is high (i.e., > 38 cm), it also predicts the risk of
impaired mobility  (10), suggesting the need to create double cutoff
points for the absolute CC (one for high values and another for low
values),  due to  a  non-linear relationship  between absolute CC and
mobility  (10). This was confirmed in this study when all of our older
women  with  elevated  CC  (>  38  cm)  had  functional  limitations
(walking distance ≤ 400 m), as seen in figure 3a.
A multiple linear regression model proposed from NHANES data (30),
including  CC  in  combination  with  sex,  race,  and  age,  was  able  to
predict up to 90 % of ASMM as measured by DXA. This approach could
be adequate to identify SMM deficit in older women were it not for its
weak relationship with functional  limitation  (8). Absolute CC values
could result in prediction errors (Fig. 3a) over time, since higher CCs
are generally  related to overweight  and obesity  (BMI > 25 kg·m-2)
characterizing a negative impact on functional performance (10). 
One of the strengths of this study involves a normalization of CC that
had not yet been proposed as predictor of SMM, although it has long
been  recommended  (2). Another  positive  finding  was  that
alternatively to most studies that used ASMM·height-2 derived from
DXA  as  an  SMM  indicator,  our  model  was  able  to  discriminate
functional  limitation  using  normalized  CC  in  an  linear  expression
approach. The procedure to generate a cutoff point at -2 SD of the
mean value for young women is a recommended method to approach
SMM parameters (2). This study also has its limitations: for example,
the sample was not random or stratified. Another limitation is that
muscle function and quality were not analyzed in the present study.
These limitations, as well as others such as perceptual-motor factors,
affect the relationship between CC and performance, and thus can be
aims for future studies. Nevertheless, the application of the model to
other populations has an unconfirmed predictive value and requires
further development before being adopted into clinical practice.
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One implication of our findings for clinical practice supports the use of
normalized  CC  by  BMI  as  a  simple  and  inexpensive  indicator  for
monitoring SMM losses associated with functional  capacity in older
women. Another implication involves choosing variables that predict
incident adverse health-related outcomes in older adults to identify
potential  sarcopenia  by  CC,  allowing  intervention  or  prophylactic
decisions to be made when monitoring the health of older women.
Our  CC·BMI-1 model  classified  12 %  of  older  women  with  reduced
SMM,  and  39 %  of  older  women  as  having  functional  limitation
(walking ≤ 400 m). The cutoff point at -2 SD of mean CC·BMI -1 for
young women (≤ 1.10 cm·kg-1·m-2)  was lower than the cutoff point
based on functional limitation (≤ 1.33 cm·kg-1·m-2) as estimated by
the ROC curve (data not shown), which would classify older women
with mobility problems. This corrects the distortion of overestimating
functional  limitation  (39 %)  present  in  the  current  classification  of
SMM deficit (12 %), closer to the worldwide prevalence of sarcopenia
(≅ 10 %) (3) but still below the prevalence of Brazilian older women
(≅  20 %)  (4). But  we emphasize  that  we did  not  consider  muscle
strength here, the first criterion for the diagnosis of sarcopenia, but
only  the  second  criterion  (low  SMM)  (2).  Maybe  this  should  be
recommended for further researches.
In  conclusion,  our  hypothesis  that  normalized  CC helps  to  identify
functional  limitation  as  a  prognostic  tool  to  estimate  the  risk  of
sarcopenia has been confirmed. Our findings support the use of CC
normalized by BMI to identify low SMM as an expression of functional
limitation in older women, without the inverted U-shaped relationship
bias.  Monitoring  the  functional  limitations  resulting  from ageing  in
women may be feasible using this simple and inexpensive approach,
particularly given the high prevalence of sarcopenia in older women in
low- to middle-income countries. Its use can be a viable alternative in
clinical practice when sophisticated methods for identifying the low
SMM associated with functional limitation are not available.
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Table  I.  A  descriptive  analysis  of  young  and  older  women,  body
measurements,  and  calf-circumference  (CC)  cutoff  points,  absolute
and  normalized,  to  identify  low  skeletal  muscle  mass  (SMM)  and
functional performance in older women
variables unit








older women (n = 67)
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limitation†
(f)       
39 
%
    
CI:  confidence interval;  SD:  standard deviation;  MMSE: Mini  Mental
State Examination; BMI: body mass index; CC: calf circumference. *In
the six-minute walk test; †Walking distance ≤ 400 m.
18
19
Table  II.  Likelihood  of  the  occurrence  of  a  functional  limitation*












(1: ≤ 400 m and 0: > 400 m)
CC   2.79 0.095 2.56   1.16
6
CC·body mass-1   4.89 0.027 4.33 <
0.001
CC·height-2   0.28 0.595 0.28   1.10
2
CC·BMI-1 10.77 0.001 8.72   0.00
2
*Walking distance ≤ 400 m in the six-minute walk test;  BMI:  body
mass index; χ2: chi-square; OR: odds ratio. 
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Table III. Studies that proposed cutoff points to identify low skeletal
muscle mass (SMM) by calf circumference (CC), identified from the












































































































































ASMM:  appendicular  skeletal  muscle  mass;  SMM:  skeletal  muscle
mass; Sens.: sensitivity; Spec.: specificity. *Calculated from the fat-
free  mass  obtained  by  bioelectrical  impedance  analysis.  †Serum
albumin < 30 g·L-1 or BMI < 19 kg·m-².
Fig. 1. Flow chart of women recruited by age groups.
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Fig. 2. Accuracy of absolute and normalized calf circumference (CC) to
detect functional limitation (≤ 400 m in six-minute walk test) in older
women,  represented  by  the  ROC curve  and  area  under  the  curve
(AUC).
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Fig. 3. Comparison of the inverted U-shaped relationship (a) between
absolute CC and mobility (six-minute walk test) with the linear (b) one
of the indicator proposed in this study (CC·BMI-1) in older women (n =
67).
Walking distance (m)
CC (cm) CC∙BMI­1 (cm∙kg­1∙m­2)
